Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy. [electronic resource]
Producer: 20200518Description: 142 p. digitalISSN:- 1465-542X
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers, Tumor
- Breast Neoplasms -- drug therapy
- Female
- Gene Expression
- Histocompatibility Antigens Class I -- genetics
- Humans
- Immunohistochemistry
- Lymphocytes, Tumor-Infiltrating -- immunology
- Neoadjuvant Therapy
- Neoplasm Staging
- Prognosis
- Proportional Hazards Models
- Receptor, ErbB-2 -- deficiency
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Treatment Outcome
- Tumor Microenvironment
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.